Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
During oncogenesis, tumor cells present specific carbohydrate chains that are new targets for cancer immunotherapy. Whereas these tumor-associated carbohydrates (TACA) can be targeted with antibodies and vaccination approaches, TACA including sialic acid-containing glycans are able to inhibit antica...
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
BMJ Publishing Group
2020-10-01
|
| Serie: | Journal for ImmunoTherapy of Cancer |
| Länkar: | https://jitc.bmj.com/content/8/2/e001222.full |